Profile | GDS5420 / 235849_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 125.71 | 45 |
GSM1296119 | B_lesional_pre-dose | 2096.88 | 90 |
GSM1296076 | C_lesional_pre-dose | 490.93 | 68 |
GSM1296092 | D_lesional_pre-dose | 486.05 | 68 |
GSM1296103 | E_lesional_pre-dose | 127.08 | 45 |
GSM1296078 | F_lesional_pre-dose | 1037.68 | 79 |
GSM1296107 | G_lesional_pre-dose | 1123.59 | 81 |
GSM1296109 | H_lesional_pre-dose | 405.62 | 64 |
GSM1296080 | I_lesional_pre-dose | 30.37 | 25 |
GSM1296090 | J_lesional_pre-dose | 1640.33 | 86 |
GSM1296074 | K_lesional_pre-dose | 532.9 | 70 |
GSM1296111 | L_lesional_pre-dose | 1822.95 | 88 |
GSM1296099 | M_lesional_pre-dose | 744.64 | 74 |
GSM1296086 | O_lesional_pre-dose | 507.12 | 68 |
GSM1296117 | P_lesional_pre-dose | 748.08 | 75 |
GSM1296113 | Q_lesional_pre-dose | 1116.8 | 81 |
GSM1296096 | R_lesional_pre-dose | 1063.38 | 80 |
GSM1296105 | S_lesional_pre-dose | 1489.09 | 85 |
GSM1296098 | T_lesional_pre-dose | 26.44 | 18 |
GSM1296101 | U_lesional_pre-dose | 932.4 | 78 |
GSM1296121 | V_lesional_pre-dose | 977.33 | 79 |
GSM1296088 | W_lesional_pre-dose | 494.88 | 67 |
GSM1296082 | X_lesional_pre-dose | 296.23 | 60 |
GSM1296115 | Y_lesional_pre-dose | 1352.83 | 84 |
GSM1296084 | Z_lesional_pre-dose | 707.31 | 73 |
GSM1296072 | B_lesional_day8 | 1841.97 | 88 |
GSM1296069 | L_lesional_day8 | 2585.77 | 93 |
GSM1296071 | P_lesional_day8 | 2515.59 | 93 |
GSM1296070 | Y_lesional_day8 | 1963.99 | 90 |
GSM1296073 | V_lesional_day8 | 926.35 | 78 |
GSM1296034 | A_lesional_day15 | 476.49 | 66 |
GSM1296041 | G_lesional_day15 | 786.04 | 75 |
GSM1296035 | R_lesional_day15 | 1295 | 83 |
GSM1296038 | U_lesional_day15 | 1709.05 | 87 |
GSM1296047 | B_lesional_day15 | 1020.45 | 80 |
GSM1296039 | E_lesional_day15 | 574.91 | 70 |
GSM1296042 | H_lesional_day15 | 1402.64 | 85 |
GSM1296043 | L_lesional_day15 | 2109.69 | 91 |
GSM1296037 | M_lesional_day15 | 1519.17 | 86 |
GSM1296046 | P_lesional_day15 | 2308.18 | 92 |
GSM1296044 | Q_lesional_day15 | 2313.09 | 92 |
GSM1296045 | Y_lesional_day15 | 3444.04 | 96 |
GSM1296025 | C_lesional_day15 | 604.88 | 71 |
GSM1296033 | D_lesional_day15 | 497.26 | 67 |
GSM1296027 | I_lesional_day15 | 314.62 | 61 |
GSM1296032 | J_lesional_day15 | 567.52 | 69 |
GSM1296024 | K_lesional_day15 | 380.3 | 63 |
GSM1296031 | W_lesional_day15 | 1995.87 | 90 |
GSM1296028 | X_lesional_day15 | 277.29 | 58 |
GSM1296029 | Z_lesional_day15 | 1073.23 | 80 |
GSM1296026 | F_lesional_day15 | 381.56 | 64 |
GSM1296030 | O_lesional_day15 | 170.64 | 52 |
GSM1296040 | S_lesional_day15 | 578.99 | 70 |
GSM1296036 | T_lesional_day15 | 148.04 | 46 |
GSM1296048 | V_lesional_day15 | 1869.36 | 88 |
GSM1296059 | A_lesional_day43 | 1568.79 | 86 |
GSM1296066 | G_lesional_day43 | 989.29 | 79 |
GSM1296060 | R_lesional_day43 | 1179.12 | 82 |
GSM1296063 | U_lesional_day43 | 2663.73 | 92 |
GSM1296064 | E_lesional_day43 | 1092.17 | 80 |
GSM1296067 | H_lesional_day43 | 1126.31 | 81 |
GSM1296062 | M_lesional_day43 | 197.1 | 52 |
GSM1296068 | Q_lesional_day43 | 2508.75 | 93 |
GSM1296050 | C_lesional_day43 | 1836.22 | 88 |
GSM1296057 | D_lesional_day43 | 1662.82 | 87 |
GSM1296052 | I_lesional_day43 | 811.21 | 75 |
GSM1296054 | J_lesional_day43 | 554.65 | 69 |
GSM1296049 | K_lesional_day43 | 462.5 | 66 |
GSM1296055 | W_lesional_day43 | 3386.47 | 95 |
GSM1296053 | X_lesional_day43 | 265.04 | 57 |
GSM1296058 | Z_lesional_day43 | 3690.02 | 96 |
GSM1296051 | F_lesional_day43 | 842.51 | 76 |
GSM1296056 | O_lesional_day43 | 1045.4 | 79 |
GSM1296065 | S_lesional_day43 | 2231.96 | 91 |
GSM1296061 | T_lesional_day43 | 110.1 | 42 |
GSM1296095 | A_non-lesional_pre-dose | 2429.56 | 91 |
GSM1296120 | B_non-lesional_pre-dose | 2269.95 | 91 |
GSM1296077 | C_non-lesional_pre-dose | 1376.09 | 84 |
GSM1296093 | D_non-lesional_pre-dose | 482.59 | 66 |
GSM1296104 | E_non-lesional_pre-dose | 1254.05 | 83 |
GSM1296079 | F_non-lesional_pre-dose | 1163.36 | 81 |
GSM1296108 | G_non-lesional_pre-dose | 2384.73 | 91 |
GSM1296110 | H_non-lesional_pre-dose | 2390.21 | 92 |
GSM1296081 | I_non-lesional_pre-dose | 802.89 | 75 |
GSM1296091 | J_non-lesional_pre-dose | 251.08 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 2751.35 | 92 |
GSM1296112 | L_non-lesional_pre-dose | 3279.39 | 96 |
GSM1296100 | M_non-lesional_pre-dose | 760.61 | 74 |
GSM1296087 | O_non-lesional_pre-dose | 770.08 | 75 |
GSM1296118 | P_non-lesional_pre-dose | 1239.59 | 83 |
GSM1296114 | Q_non-lesional_pre-dose | 2165.24 | 91 |
GSM1296097 | R_non-lesional_pre-dose | 3667.83 | 95 |
GSM1296106 | S_non-lesional_pre-dose | 2266.44 | 91 |
GSM1296102 | U_non-lesional_pre-dose | 1691.65 | 88 |
GSM1296122 | V_non-lesional_pre-dose | 1389.11 | 85 |
GSM1296089 | W_non-lesional_pre-dose | 3701.75 | 96 |
GSM1296083 | X_non-lesional_pre-dose | 729.17 | 74 |
GSM1296116 | Y_non-lesional_pre-dose | 2867.46 | 94 |
GSM1296085 | Z_non-lesional_pre-dose | 532.88 | 69 |